United States v. Peter L. Francesco

725 F.2d 817, 14 Fed. R. Serv. 1756, 1984 U.S. App. LEXIS 26219
CourtCourt of Appeals for the First Circuit
DecidedJanuary 20, 1984
Docket83-1414
StatusPublished
Cited by57 cases

This text of 725 F.2d 817 (United States v. Peter L. Francesco) is published on Counsel Stack Legal Research, covering Court of Appeals for the First Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Peter L. Francesco, 725 F.2d 817, 14 Fed. R. Serv. 1756, 1984 U.S. App. LEXIS 26219 (1st Cir. 1984).

Opinion

SWYGERT, Senior Circuit Judge.

On December 14, 1982 on the basis of an informant’s tip, agents of the Drug Enforcement Administration (“DEA”), maintained surveillance on defendant-appellant Peter Francesco. They observed the defendant drive his car from his residence in Arlington, Massachusetts to the Hampton Toll Plaza in New Hampshire. The DEA officials arrested the defendant immediately upon entering a parking area in the toll plaza. A brown paper package was recovered from his car. Search warrants were obtained for the package and for the defendant’s residence in Arlington. The package was found to contain approximately one kilogram of a white powdery substance identified as cocaine. The search of the house turned up various implements used in weighing and packaging cocaine for resale and a small amount of a substance identified as cocaine hydrochloride. The defendant was charged in a one count indictment with possession with intent to distribute a Schedule II controlled substance in violation of the Comprehensive Drug Abuse Prevention and Control Act of 1970, (“Drug Control Act” or “Act”), 21 U.S.C. § 841 (1982).

Prior to trial, the defendant filed motions to suppress evidence and for discovery of information regarding the confidential government informant(s) used in the case. The district court held an evidentiary hearing on the motions to suppress and denied the motions. The court also held a hearing in camera to question DEA agents regarding the informants) involved in the case. The court determined that disclosure of the identity of the informant(s) was not required.

The defendant was afforded a jury trial. The government’s case consisted of testimony from several DEA agents and other law enforcement personnel, and two DEA chemists. After the government rested, the defendant moved for a judgment of acquittal alleging among other things that the government had failed to prove that the substances seized from him were Schedule II controlled substances as defined in the Drug Control Act. The motion was denied. The defense then called its witnesses, which included one Michael a/k/a Mickey Mar- *820 rone, who asserted his fifth amendment privilege not to testify.

At the close of the evidence, the parties submitted requests for jury instructions. One of the defendant’s proposed instructions concerned the government’s burden of proving that the substances seized from him fell within the statutory definition of a Schedule II controlled substance. At this point, the government moved to reopen its case to call a third chemist to testify regarding the tests conducted on the seized substances by two DEA chemists who had testified previously. The court granted the government’s request to reopen but refused on the basis of the hearsay prohibition to allow the chemist to testify regarding tests conducted by the other chemists.

The jury returned a guilty verdict. The defendant’s motion for judgment notwithstanding the verdict was denied, and he was sentenced to a term of twelve years incarceration, fined $25,000.00, and placed under a special probation term of ten years. We affirm the conviction.

I

The defendant’s primary claim concerns what is known as the “cocaine isomer” defense or strategy. 1 According to this defense, substances exist, in theory at least, that may properly be called “cocaine” but are not controlled substances within the definition of the Drug Control Act.

The Act designates as a Schedule II controlled substance:

Coca leaves and any salt, compound, derivative, or preparation of coca leaves, and any salt, compound, derivative, or preparation thereof which is chemically equivalent or identical with any of these substances ....

21 U.S.C. § 812(c), Schedule II(a)(4) (1982). The experts appear to agree that there are eight known isomers of cocaine. See United States v. Ross, supra, at 617; United States v. Kolenda, supra, 697 F.2d at 150. There is some disagreement, however, as to the nature of these eight cocaine isomers.

The defendant’s counsel explained to this court at oral argument, as we understand it, that although all eight isomers are derived from the coca leaf, only two of the isomers, L-cocaine and D-cocaine, are narcotic and come within the intended scope of the Drug Control Act. In United States v. Orzechowski, supra, however, the defense argued that D-cocaine was a synthetic substance rather than a derivative of the coca leaf and was not a controlled substance under the Act. A defense expert testified that D-cocaine and L-cocaine have different molecular compositions and “react differently with other chemical reagents and in living organisms.” 547 F.2d at 981. See also United States v. Bockius, supra, 564 F.2d at 1195.

In United States v. Kolenda, supra, the defense argued that no isomers of cocaine are controlled substances under the Act. The court appeared to find that all compounds of cocaine are isomeric and that all cocaine isomers are Schedule II controlled substances. Admitting that the substance recovered from defendant was a cocaine isomer, the court stated, “the evidence shows that all forms of cocaine compound *821 are isomers of each other .... There can be no doubt that the substance involved in the present case is derived from coca leaves and falls within the statutory definition.” 697 F.2d at 150.

In United States v. Ross, supra, the Second Circuit offered, in our opinion, the most cogent analysis of the cocaine isomer theory, The court explained that only L-cocaine is a derivative of the coca leaf and that the seven other cocaine isomers are synthetic compounds that “are ‘controlled’ by the statute only if they are ‘chemically equivalent or identical with’ L-cocaine.” At 618.

Whatever the basis for the isomer defense, we understand the gist of the defendant’s argument in this case to be that the government failed to prove that the substances recovered from his car and his home were controlled substances as defined in the Drug Control Act. The government experts testified only that the substance recovered from the defendant’s car was “cocaine” and that the substance recovered from his house was “cocaine hydrochloride.” The term isomer was never mentioned. There was no testimony that the substances were derivatives of the coca leaf or a chemical equivalent thereof, and the experts did not even indicate what tests were conducted on the substances. The defendant argues that the trial court should have found this evidence insufficient as a matter of law to prove that he possessed a Schedule II controlled substance. The defendant further argues that the court’s instruction to the jury, stating that cocaine, as a matter of law, is a Schedule II controlled substance, constituted reversible error. We find that, although the government’s expert testimony on the nature of the substances recovered from the defendant was woefully scant, the testimony was sufficient to support the jury instruction and the defendant’s ultimate conviction in this case.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United States v. Tommy Collier
116 F.4th 756 (Eighth Circuit, 2024)
United States v. Idris Quintell Wilkes
78 F.4th 272 (Sixth Circuit, 2023)
United States v. Awer
502 F. Supp. 2d 273 (D. Rhode Island, 2007)
Harrelson v. State
897 So. 2d 1237 (Court of Criminal Appeals of Alabama, 2004)
Virella v. USA
D. New Hampshire, 1996
United States v. James
915 F. Supp. 1092 (S.D. California, 1996)
State v. Lee
531 N.W.2d 351 (Court of Appeals of Wisconsin, 1995)
State v. White
530 N.W.2d 77 (Court of Appeals of Iowa, 1994)
United States v. Garcia
First Circuit, 1993
United States v. Vincent D. Spinosa
982 F.2d 620 (First Circuit, 1992)
United States v. Vijai B. Pandey
979 F.2d 844 (First Circuit, 1992)
United States v. Pandey
First Circuit, 1992
United States v. Victor Arias-Montoya
967 F.2d 708 (First Circuit, 1992)
Grayson v. State
593 N.E.2d 1200 (Indiana Court of Appeals, 1992)
United States v. George Franklin Patrick, Jr.
960 F.2d 950 (Eleventh Circuit, 1992)
Navajo Nation v. MacDonald
6 Navajo Rptr. 432 (Navajo Nation Supreme Court, 1991)
Pueblo v. Galindo González
129 P.R. Dec. 627 (Supreme Court of Puerto Rico, 1991)
Kowalski v. Gagne
914 F.2d 299 (First Circuit, 1990)

Cite This Page — Counsel Stack

Bluebook (online)
725 F.2d 817, 14 Fed. R. Serv. 1756, 1984 U.S. App. LEXIS 26219, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-peter-l-francesco-ca1-1984.